![]() |
![]() |
![]() |
This is an archived USAID document retained on this web site as a matter of public record.
Opening Remarks by Anne Peterson,
Assistant Administrator, Bureau for Global Health
at the Global Fund Press Conference
April 25, 2002
Good morning. My name is Dr. Anne Peterson, and I am the Assistant Administrator for Global Health at the U.S. Agency for International Development. I serve as an alternate representative from the United States to the board of the Global Fund.
According to estimates published last year in the journal Science, $7 - 10 billion is needed annually in the developing world to prevent new HIV infections, care for people living with HIV and AIDS, and provide limited treatment with antiretroviral drugs. In addition to these costs, an additional $2 billion is needed to address TB and malaria each year.
These estimates include funding from all sources, including national, bilateral and multilateral programs. The creation of the Global Fund was meant to serve as a supplement and a catalyst to funds that are currently expended through these other sources.
Thanks to the support and patronage of Kofi Annan, the Global Fund has quickly gotten off the ground. However, this Fund is not a UN fund, but a new, independent entity, designed to encourage new funding and governed by an 18-member board.
While the need still exceeds current resources, the Fund has raised more than $2 billion in total pledges in less than a year. The United States is modeling increased commitment by increasing funding through both the Fund and bilateral programs. The U.S. has pledged $500 million to the Fund - approximately one-quarter of the pledges to date.
In fiscal year 2003, the U.S. will spend more than a billion dollars on international AIDS prevention, care and research programs. Other national governments, bilateral donors, foundations and the private sector are all increasing their funding dedicated to AIDS.
The first round of grants reflects the Global Fund's strong commitment to a comprehensive approach to fighting HIV/AIDS, TB and malaria that balances prevention and treatment.
The Fund has great potential to attract new resources to fight AIDS, TB and malaria, and to put these new resources to work quickly. The Fund is innovative and creative, but it also must ensure effectiveness. Good proposals that help reduce the burden of these three diseases will encourage a broader range of donors to become more involved. Monitoring the progress of these proposals will be essential. As positive results are reported, the global donor community will need to reassess their contributions.
Last Updated on: January 02, 2009 |